Anja Harmeier
Overview
Explore the profile of Anja Harmeier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matte A, Federti E, Winter M, Koerner A, Harmeier A, Mazer N, et al.
JCI Insight
. 2019 Oct;
4(22).
PMID: 31593554
Anemia of β-thalassemia is caused by ineffective erythropoiesis and reduced red cell survival. Several lines of evidence indicate that iron/heme restriction is a potential therapeutic strategy for the disease. Glycine...
2.
Richter H, Satz A, Bedoucha M, Buettelmann B, Petersen A, Harmeier A, et al.
ACS Chem Biol
. 2018 Nov;
14(1):37-49.
PMID: 30452219
The importance of Discoidin Domain Receptor 1 (DDR1) in renal fibrosis has been shown via gene knockout and use of antisense oligonucleotides; however, these techniques act via a reduction of...
3.
Harmeier A, Meyer C, Staempfli A, Casagrande F, Petrinovic M, Zhang Y, et al.
Front Pharmacol
. 2018 Aug;
9:924.
PMID: 30158871
Individuals of many species rely on odors to communicate, find breeding partners, locate resources and sense dangers. In vertebrates, odorants are detected by chemosensory receptors of the olfactory system. One...
4.
Barucker C, Bittner H, Chang P, Cameron S, Hancock M, Liebsch F, et al.
Sci Rep
. 2015 Oct;
5:15410.
PMID: 26510576
The amyloid-β42 (Aβ42) peptide is believed to be the main culprit in the pathogenesis of Alzheimer disease (AD), impairing synaptic function and initiating neuronal degeneration. Soluble Aβ42 oligomers are highly...
5.
Harmeier A, Obermueller S, Meyer C, Revel F, Buchy D, Chaboz S, et al.
Eur Neuropsychopharmacol
. 2015 Sep;
25(11):2049-61.
PMID: 26372541
Trace amine-associated receptor 1 (TAAR1) activation by selective endogenous agonists modulates dopaminergic neurotransmission. This results in antipsychotic-like behavior in vivo which might be initiated by an interaction of TAAR1 and...
6.
Cotter R, Pei Y, Mus L, Harmeier A, Gainetdinov R, Hoener M, et al.
Front Neurosci
. 2015 Mar;
9:39.
PMID: 25762894
The newly discovered trace amine-associated receptor 1 (TAAR1) has the ability to regulate both dopamine function and psychostimulant action. Here, we tested in rats the ability of RO5203648, a selective...
7.
Espinoza S, Lignani G, Caffino L, Maggi S, Sukhanov I, Leo D, et al.
Neuropsychopharmacology
. 2015 Mar;
40(9):2217-27.
PMID: 25749299
Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor expressed in the mammalian brain and known to influence subcortical monoaminergic transmission. Monoamines, such as dopamine, also play an important...
8.
Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke C, et al.
J Alzheimers Dis
. 2014 Oct;
44(2):613-24.
PMID: 25318543
The pathogenesis of Alzheimer's disease (AD) is characterized by the aggregation of amyloid-β (Aβ) peptides leading to deposition of senile plaques and a progressive decline of cognitive functions, which currently...
9.
Barucker C, Harmeier A, Weiske J, Fauler B, Albring K, Prokop S, et al.
J Biol Chem
. 2014 Jun;
289(29):20182-91.
PMID: 24878959
Although soluble species of the amyloid-β peptide Aβ42 correlate with disease symptoms in Alzheimer disease, little is known about the biological activities of amyloid-β (Aβ). Here, we show that Aβ...
10.
Willi R, Harmeier A, Giovanoli S, Meyer U
Neuropharmacology
. 2013 May;
73:56-65.
PMID: 23707483
Protein kinase B (AKT) and glycogen synthase kinase 3 beta (GSK3β) are two protein kinases involved in dopaminergic signaling. Dopamine-associated neuropsychiatric illnesses such as schizophrenia and bipolar disorder seem to...